Abstract
Arsha (hemorrhoids) is engorgement of the hemorrhoidal venous plexus, characterized by bleeding per rectum, constipation, pain, prolapse and discharge. The earliest reference of Arsha is available in Acharya Charaka, Sushruta and Kashyap Samhita. In modern point of view, it can be correlated with Haemorrhoids. In this study total 10 patients of Arsha having signs and symptoms of same, selected from Arogyashala Rugnalaya OPD of Shalyatantra Department. The patients were treated with prepared “Arshahar malam” to be applied locally for twise a day upto 10 days. The reference of Arshahar malam taken from various texts of Ayurvedic samhitas. It contains Nagkeshar, Lodhra, Nirgundi, lajjalu, Bheemseni Karpoor, Yasad Bhama And Tila Taila in appropriate proportion. All these drugs have property to subside the different symptoms belongs to Arsha. The combind effect of all these drugs are seen in this study.
 Assessment was done on the basis of criteria such as bleeding, shotha according to grade of pile mass, and itching. On observation, result showed reduction of bleeding, shotha, and itching with advantages like affordable cost-effective and more acceptable to different categories of people, etc. were recorded in the Arshahar malam-treated group. No any complication seen in patients during follow up periods.
Highlights
All the patients have completed the course of treatment with Arshahar malam for local application daily for 10 days
Patient diagnosed as Arsha with sign and symptoms like- bleeding, shotha according to grade, burning, itching, H/o- constipation, rectal bleeding
TOTAL EFFECT IN PERCENTAGE Total effect of Arshahar malam therapy shows 67.91% relief in all the symptoms of patients enrolled for preliminary study
Summary
All the patients have completed the course of treatment with Arshahar malam for local application daily for 10 days. The symptoms like bleeding,shotha according to grade and itching recorded daily in the proforma designed especially for this study. 3. Patient diagnosed as Arsha with sign and symptoms like- bleeding, shotha according to grade, burning, itching, H/o- constipation, rectal bleeding. Patient not willing to participate in clinical trial. 3. Immune compromised patients WITHDRAWAL CRITERIA FOR STUDY 1. 2. Patient lost for two consecutive follow ups during treatment. 3. If any adverse effects are noted while conducting clinical criteria, such patients are excluded from study. Subsequent replacement of the patient was done which are not fulfilling the selection criteria
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
